Cargando…
Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
The AGR2 and AGR3 genes have been shown by numerous groups to be functionally associated with adenocarcinoma progression and metastasis. In this paper, we explore the data available in databases concerning genomic and transcriptomic features of these two genes: the NCBI dbSNP database was used to ex...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277299/ https://www.ncbi.nlm.nih.gov/pubmed/35857928 http://dx.doi.org/10.1098/rsob.220068 |
_version_ | 1784745926742507520 |
---|---|
author | Fessart, Delphine Villamor, Ines Chevet, Eric Delom, Frederic Robert, Jacques |
author_facet | Fessart, Delphine Villamor, Ines Chevet, Eric Delom, Frederic Robert, Jacques |
author_sort | Fessart, Delphine |
collection | PubMed |
description | The AGR2 and AGR3 genes have been shown by numerous groups to be functionally associated with adenocarcinoma progression and metastasis. In this paper, we explore the data available in databases concerning genomic and transcriptomic features of these two genes: the NCBI dbSNP database was used to explore the presence and roles of constitutional SNPs, and the NCI, Cancer Cell Line Encyclopedia (CCLE) and TCGA databases were used to explore somatic mutations and copy number variations (CNVs), as well as mRNA expression of these genes in human cancer cell lines and tumours. Relationships of AGR2/3 expression with whole-genome mRNA expression and cancer features (i.e. mutations and CNVs of oncogenes and tumour suppressor genes (TSG)) were established using the CCLE and TCGA databases. In addition, the CCLE data concerning CRISPR gene extinction screens (Achilles project) of these two genes and a panel of oncogenes and TSG were explored. We observed that no functional polymorphism or recurrent mutation could be detected in AGR2 or AGR3. The expression of these genes was positively correlated with the expression of epithelial genes and inversely correlated with that of mesenchymal genes. It was also significantly associated with several cancer features, such as TP53 or SMAD4 mutations, depending on the gene and the cancer type. In addition, the CRISPR screens revealed the absence of cell fitness modification upon gene extinction, in contrast with oncogenes (cell fitness decrease) and TSG (cell fitness increase). Overall, these explorations revealed that AGR2 and AGR3 proteins appear as common non-genetic evolutionary factors in the process of human tumorigenesis. |
format | Online Article Text |
id | pubmed-9277299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Royal Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-92772992022-07-15 Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer Fessart, Delphine Villamor, Ines Chevet, Eric Delom, Frederic Robert, Jacques Open Biol Research The AGR2 and AGR3 genes have been shown by numerous groups to be functionally associated with adenocarcinoma progression and metastasis. In this paper, we explore the data available in databases concerning genomic and transcriptomic features of these two genes: the NCBI dbSNP database was used to explore the presence and roles of constitutional SNPs, and the NCI, Cancer Cell Line Encyclopedia (CCLE) and TCGA databases were used to explore somatic mutations and copy number variations (CNVs), as well as mRNA expression of these genes in human cancer cell lines and tumours. Relationships of AGR2/3 expression with whole-genome mRNA expression and cancer features (i.e. mutations and CNVs of oncogenes and tumour suppressor genes (TSG)) were established using the CCLE and TCGA databases. In addition, the CCLE data concerning CRISPR gene extinction screens (Achilles project) of these two genes and a panel of oncogenes and TSG were explored. We observed that no functional polymorphism or recurrent mutation could be detected in AGR2 or AGR3. The expression of these genes was positively correlated with the expression of epithelial genes and inversely correlated with that of mesenchymal genes. It was also significantly associated with several cancer features, such as TP53 or SMAD4 mutations, depending on the gene and the cancer type. In addition, the CRISPR screens revealed the absence of cell fitness modification upon gene extinction, in contrast with oncogenes (cell fitness decrease) and TSG (cell fitness increase). Overall, these explorations revealed that AGR2 and AGR3 proteins appear as common non-genetic evolutionary factors in the process of human tumorigenesis. The Royal Society 2022-07-13 /pmc/articles/PMC9277299/ /pubmed/35857928 http://dx.doi.org/10.1098/rsob.220068 Text en © 2022 The Authors. https://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, provided the original author and source are credited. |
spellingShingle | Research Fessart, Delphine Villamor, Ines Chevet, Eric Delom, Frederic Robert, Jacques Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer |
title | Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer |
title_full | Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer |
title_fullStr | Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer |
title_full_unstemmed | Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer |
title_short | Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer |
title_sort | integrative analysis of genomic and transcriptomic alterations of agr2 and agr3 in cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277299/ https://www.ncbi.nlm.nih.gov/pubmed/35857928 http://dx.doi.org/10.1098/rsob.220068 |
work_keys_str_mv | AT fessartdelphine integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer AT villamorines integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer AT cheveteric integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer AT delomfrederic integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer AT robertjacques integrativeanalysisofgenomicandtranscriptomicalterationsofagr2andagr3incancer |